ALVO

Alvotech
ALVO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.77B
EV
$3.96B
Shares Outstanding
303.47M
Beta
0.12

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$17.90
P/E 2025E
32.02x
P/Revenue 2025E
4.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alvotech

gainify
ALVO

Alvotech

ALVO

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company’s lead program is AVT02, a high con...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Wessman, Robert

Employees

1,012

IPO Date

2022-06-16

Headquarters

9, Rue de Bitbourg, Luxembourg City 1273, Luxembourg

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.